加载中...
广告
发布时间 | 所属地区 | 所属机构 | 语言 |
---|---|---|---|
2024年06月26日 | -- | -- | 英语 (English) 中文 |
Published date: 26 June 2024
Open opportunity - This means that the contract is currently active, and the buying department is looking for potential suppliers to fulfil the contract.
Pharmaceutical products - 33600000
WA7 2ES
£49,320,000
CF-2433800D0O000000rwimUAA
26 June 2024
29 July 2024
1pm
1 October 2024
31 May 2026
Supply contract
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Yes
No
Project title: NHS National Framework for Transition products commencing 1 October 2024
Offer reference number: CM/TNS/24/5712
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months)
Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months)
Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months)
CM/TNS/24/5712/02 - Imatinib
Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Attachments
Additional text
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.
Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:
Phone: 0800 9956035
E-mail: support-health@atamis.co.uk
Follow the instructions given in the description or the more information section.
Katie Noonan
2nd Floor Rutland House
Runcorn
WA7 2ES
GB
Is there anything wrong with this page?
猜你喜欢
加载中...
广告